Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€3.33
13.05.24
-
13.05.25
-7.07%
09:51

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Little innovation
me8 
13.05.24 0%
sell
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€0.73
13.05.23
-
13.05.24
102.74%
02:15

StockNews.com 
13.05.23 50%
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€103.20
13.05.23
-
13.05.24
6.98%
02:15

StockNews.com 
13.05.23 50%
sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.61
13.05.23
-
13.05.24
-28.93%
02:15

StockNews.com 
13.05.23 50%
sell
Insmed Inc.

Start price
Target price
Perf. (%)
€25.40
07.04.24
€15.00
30.09.25
-7.09%
13.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
07.04.24 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.40
04.02.24
€20.00
30.11.25
-77.89%
13.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€43.80
26.12.23
-
26.12.24
32.42%
13.05.24

Could be very worthwhile Investment >20% year
daimler1 
26.12.23 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.37
10.05.24
-
10.05.25
-27.99%
12.05.24

Risky Investment
thomasw 
10.05.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Traumtanz 
27.04.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Traumtanz 
27.04.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Traumtanz 
27.04.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.96
10.05.24
-
10.05.25
4.80%
11.05.24

Could be worthwhile Investment >10% per year
Global_Player 
10.05.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.50
19.04.24
-
19.04.25
-12.02%
10.05.24

Could be very worthwhile Investment >20% year
bundfuture 
19.04.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€9.43
09.05.23
€12.00
09.05.24
-54.40%
10.05.24

Could be worthwhile Investment >10% per year
melinda 
09.05.23 50%
buy
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€0.61
07.05.23
-
07.05.24
-22.31%
08.05.24

StockNews.com 
07.05.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€193.40
06.05.23
-
06.05.24
-26.81%
07.05.24

StockNews.com 
06.05.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€388.00
06.05.23
-
06.05.24
83.76%
07.05.24

StockNews.com 
06.05.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.32
05.03.24
-
05.03.25
6.69%
06.05.24

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
fenjal 
05.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.32
05.03.24
-
05.03.25
6.69%
06.05.24

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
fenjal 
05.03.24 50%
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€10.66
03.05.23
€14.47
03.05.24
171.76%
04.05.24

Piper Sandler 
03.05.23 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.50
29.04.24
€100.00
31.03.26
-0.75%
03.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€281.00
01.05.23
€317.14
01.05.24
-28.01%
02.05.24

Guggenheim 
01.05.23 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€281.00
01.05.23
€317.14
01.05.24
-28.01%
02.05.24

Guggenheim 
01.05.23 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€281.00
01.05.23
€317.14
01.05.24
-28.01%
02.05.24

Guggenheim 
01.05.23 50%
sell
Agenus Inc.

Start price
Target price
Perf. (%)
€1.37
01.05.23
-
01.05.24
-69.70%
02.05.24

Innovative
overvalued
Risky Investment
High risks for its business
ReynadJ 
01.05.23 0%